Kyle D. Monroe
13Patents
5h-index
8Co-inventors
51Inventor score
Filing activity: Aug 13, 2015 → May 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10287317B2 | Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels | Chemistry; Metallurgy | 11 | Active |
| US10568882B2 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Chemistry; Metallurgy | 6 | Active |
| US10307433B2 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | Chemistry; Metallurgy | 5 | Active |
| US10688114B2 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | Chemistry; Metallurgy | 5 | Active |
| US10865185B2 | Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity | Human Necessities | 5 | Active |
| US10034892B2 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | Chemistry; Metallurgy | 5 | Active |
| US10980801B2 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Chemistry; Metallurgy | 5 | Active |
| US10821106B2 | Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Chemistry; Metallurgy | 4 | Active |
| US11925637B2 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Chemistry; Metallurgy | 0 | Active |
| US11026957B2 | Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands | Chemistry; Metallurgy | 0 | Active |
| US11945782B2 | Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity | Human Necessities | 0 | Active |
| US11944619B2 | Phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Chemistry; Metallurgy | 0 | Active |
| US11771710B2 | Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.